Running a small business feels like juggling a dozen tasks at once. You are the CEO, marketer, salesperson, and janitor all ...

Get key Q3 2025 earnings call insights on Cytosorbents (CTSO): growth drivers, FDA progress, cost controls, and outlook.

Coterra Energy stands out for cash flow stability, strong dividends, and undervaluation. Read here for an analysis of CTRA stock and why it's rated a buy.

BofA Securities maintains Buy on Chevron with $183 target, citing strong free cash flow, Hess synergies, structural cost ...

Chevron projects 10%+ EPS growth, higher free cash flow, and strategic oil and gas expansion. The company targets 2–3% annual oil and gas production growth and $70 Brent breakeven.

By bne IntelliNews US-based supermajor Chevron unveiled its plans for the next five years at its investor day on November 12.

At its investor day, Chevron Corporation (NYSE: CVX) outlined its five-year plan to 2030 and how it intends to deliver sustained cash flow growth, further strengthen its portfolio, advance power ...

On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...